Complete Filing Data
Bodhi Tree Biotechnology Inc reported Operating Income Loss of -$147.6 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bodhi Tree Biotechnology Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income * | -$149.7K |
| Operating Income Loss | -$147.6K |
| General And Administrative Expense | $164.6K |
| Revenues | $17.0K |
| Loss Before Provision For Income Taxes | -$147.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$147.6K |
| Comprehensive Income Net Of Tax | |
| Other Nonoperating Income Expense | $2.00 |
| Interest Income Expense Net | $2.00 |
| Income Tax Expense Benefit | $2.1K |
| Income Taxes Paid | $2.1K |
| Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | -$52.9K | -$20.8K | -$53.4K | -$64.8K | $9.7K | -$116.00 |
| Operating Income Loss | -$52.9K | -$20.0K | -$52.2K | -$64.8K | $9.7K | -$116.00 |
| General And Administrative Expense | $52.9K | $20.0K | $52.2K | $69.8K | $5.3K | $116.00 |
| Revenues | $0.00 | $5.0K | $15.0K | |||
| Loss Before Provision For Income Taxes | -$52.9K | -$20.0K | -$64.8K | $9.7K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$52.9K | -$20.0K | -$64.8K | $9.7K | ||
| Comprehensive Income Net Of Tax | -$20.8K | -$53.4K | $9.7K | -$116.00 | ||
| Other Nonoperating Income Expense | $1.00 | $1.00 | $1.00 | |||
| Interest Income Expense Net | $1.00 | $1.00 | $1.00 | |||
| Income Tax Expense Benefit | $800.00 | $1.3K | ||||
| Income Taxes Paid | ||||||
| Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax | $52.2K | $116.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||
| Retained Earnings Accumulated Deficit | -$62.0K | |
| Liabilities And Stockholders Equity | $269.3K | |
| Common Stock Value | $2.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$150.2K | |
| Assets | $269.3K | |
| Liabilities Current | $500.00 | |
| Liabilities | $500.00 | |
| Additional Paid In Capital Common Stock |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $66.2K | $119.2K | $129.8K | $150.6K | $204.1K | $268.8K | $59.6K | $48.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $47.4K | $109.4K | $119.5K | $144.2K | $194.3K | $259.6K | $69.8K | $48.9K |
| Retained Earnings Accumulated Deficit | -$264.6K | -$211.6K | -$200.9K | -$180.2K | ||||
| Liabilities And Stockholders Equity | $69.7K | $119.2K | $129.8K | $150.6K | ||||
| Common Stock Value | $2.5K | $2.5K | $2.5K | $2.5K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$62.0K | -$65.3K | $48.9K | |||||
| Assets | $69.7K | $119.2K | $129.8K | $150.6K | ||||
| Liabilities Current | $3.5K | |||||||
| Liabilities | $3.5K | |||||||
| Additional Paid In Capital Common Stock | $328.2K | $328.2K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$150.2K |
| Increase Decrease In Due To Related Parties | -$500.00 |
| Increase Decrease In Prepaid Expense | |
| Net Cash Provided By Used In Financing Activities | |
| Increase Decrease In Customer Advances |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q1 2024 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$62.0K | -$65.3K | $384.00 |
| Increase Decrease In Due To Related Parties | $3.5K | $500.00 | |
| Increase Decrease In Prepaid Expense | $12.6K | ||
| Net Cash Provided By Used In Financing Activities | $48.5K | ||
| Increase Decrease In Customer Advances | -$500.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 25.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 25.4M | |
| Preferred Stock Shares Outstanding | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | |
| Preferred Stock Shares Authorized | 30.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | |
| Earnings Per Share Diluted | $-0.01 | |
| Earnings Per Share Basic | $-0.01 | |
| Common Stock Shares Outstanding | 25.4M | |
| Common Stock Shares Issued | 25.4M | |
| Common Stock Shares Authorized | 320.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | |
| Weighted Average Number Of Common Shares Used In Per Share Calculations Basic And Diluted | ||
| Proceeds From Shares Issued To Founder | ||
| Common Shares Issued To Founder |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 25.4M | 25.4M | 25.4M | 16.6M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 25.4M | 25.4M | 25.4M | 16.6M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 30.0M | 30.0M | 30.0M | 30.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Earnings Per Share Diluted | $-0.01 | $0.00 | $0.00 | $0.00 | |||
| Earnings Per Share Basic | $-0.01 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 25.4M | 25.4M | 25.4M | 25.4M | |||
| Common Stock Shares Issued | 25.4M | 25.4M | 25.4M | 25.4M | |||
| Common Stock Shares Authorized | 320.0M | 320.0M | 320.0M | 320.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Common Shares Used In Per Share Calculations Basic And Diluted | $25,441,042.00 | $2,789,378.00 | |||||
| Proceeds From Shares Issued To Founder | 48.5K | ||||||
| Common Shares Issued To Founder | 48.5K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 |
|---|---|
| Prepaid Expense Current | $9.8K |
| Due To Related Party | $500.00 |
| Additional Paid In Capital | $328.2K |
| Income Loss Attributable To Parent | |
| Basic And Diluted Loss Per Common Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|
| Prepaid Expense Current | $22.3K | $9.8K | $10.3K | $6.5K | |
| Due To Related Party | $3.5K | $0.00 | $0.00 | $0.00 | |
| Additional Paid In Capital | $328.2K | $328.2K | $328.2K | ||
| Income Loss Attributable To Parent | -$52.2K | -$116.00 | |||
| Basic And Diluted Loss Per Common Share | $0.00 | $0.00 |
Most recent annual filing with the SEC: December 29, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.